BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:7918@myasthenia.org
DTSTART;TZID=America/New_York:20250930T110000
DTEND;TZID=America/New_York:20250930T120000
DTSTAMP:20250917T220422Z
URL:https://myasthenia.org/events/live-cme-harnessing-approved-and-emergin
 g-fcrn-blockers-across-subtypes-in-antibody-positive-generalized-myastheni
 a-gravis/
SUMMARY:Live CME: Harnessing Approved and Emerging FcRn Blockers Across Sub
 types in Antibody-Positive Generalized Myasthenia Gravis
DESCRIPTION:\n\nFOR HEALTHCARE PROVIDERS\n\n\n\nLive CME: Harnessing Approv
 ed and Emerging FcRn Blockers Across Subtypes in Antibody-Positive General
 ized Myasthenia Gravis\n\n\n\nTuesday\, September 30 11:00 AM ET / 8:00 AM
  PT\n\n\n\nAs part of our mission to empower patients and pursue a cure fo
 r MG\, MGFA is proud to offer this free CME-accredited educational session
  on emerging FcRn blockers in antibody-positive generalized myasthenia gra
 vis (gMG). Expert neurologists Dr. Gil Wolfe and Dr. Tuan Vu will provide 
 real-world cases and insights to help providers navigate diagnostic testin
 g\, treatment selection\, and emerging pharmacology in gMG.\n\n\n\nDesigne
 d for neurologists and other HCPs\, the program delivers real-world clinic
 al guidance to help improve patient care today while driving awareness of 
 new therapeutic possibilities on the horizon.\n\n\n\nCME: 1.0 AMA PRA Cate
 gory 1 Credits™\n\n\n\nPresented in partnership with NORD and Medlive\n\
 n\n\nSave Your Spot\n\n\n\n\n\n\n\n\n\n\n\n&nbsp\;\n\n\n\n\n\n\n\n
CATEGORIES:Events
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20250309T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR